Systane® Ultra Preservative Free Lubricant Eye Drops
- Disease/Condition
- Dry Eye
- Drug/Device/Intervention
- Polyethylene glycol 400 and propylene glycol solution/drops
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Alcon Research
- Location
- Fort Worth, United States of America
- Phase
- N/A
- Start date
- Sep 01, 2023
- End date
- Mar 01, 2024
- Enrollment
- 68 participants
Mean overall IDEEL-Symptom Bother(SB) score - Group 1,Resultant overall CLDEQ-8 score - Group 2
The purpose of this post-market clinical follow-up (PMCF) study is to assess the performance
 and safety of Systane Ultra Preservative-Free (PF) in subjects experiencing dry eye symptoms
 (Group 1) and contact lens (CL) wearers experiencing discomfort due to CL-related dryness
 (Group 2). Statistical analyses will be presented by group.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05902364
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05902364 through Pure Global AI's free database. This phase not specified trial is sponsored by Alcon Research and is currently Not yet recruiting. The study focuses on Dry Eye. Target enrollment is 68 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.